Kehao Zhu

Also affiliated with Shanxi Medical University, University of Washington, Shanxi Provincial People’s Hospital

MedicineMathematicsDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer”.

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Designing cancer screening trials for reduction in late-stage cancer incidence

Biometrics(2024)10.1093/biomtc/ujae097

N/A

0DataRank · unranked

1 citations

Ying‐Qi Zhao, Yingye Zheng, Kehao Zhu

Weighted Brier Score -- an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration

arXiv (Cornell University)(2024)10.48550/arxiv.2408.01626

N/A

0DataRank · unranked

0 citations

Yingye Zheng, Kwun Chuen Gary Chan, Kehao Zhu

Weighted Brier Score—An Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration

Statistics in Biosciences(2025)10.1007/s12561-025-09505-5

N/A

0DataRank · unranked

5 citations

Yingye Zheng, Kwun Chuen Gary Chan, Kehao Zhu